Curtis R. Pickering, Ph.D. - Publications

Affiliations: 
2008 Cell Biology University of California, San Francisco, San Francisco, CA 
Area:
Oncology, Cell Biology

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Stewart CA, Gay CM, Ramkumar K, Cargill KR, Cardnell RJ, Nilsson MB, Heeke S, Park EM, Kundu ST, Diao L, Wang Q, Shen L, Xi Y, Maria Della Corte C, Fan Y, ... ... Pickering CR, et al. SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models. Biorxiv : the Preprint Server For Biology. PMID 32577652 DOI: 10.1101/2020.05.28.122291  0.32
2018 Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 33: 244-258.e10. PMID 29438696 DOI: 10.1016/J.Ccell.2018.01.003  0.32
2017 Gadhikar MA, Zhang J, Shen L, Rao X, Wang J, Zhao M, Kalu NN, Johnson FM, Byers LA, Heymach J, Hittelman WN, Udayakumar D, Pandita RK, Pandita TK, Pickering CR, et al. CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition. Cancer Research. PMID 29229598 DOI: 10.1158/0008-5472.Can-17-2802  0.32
2017 Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, ... ... Pickering CR, et al. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer. PMID 29053175 DOI: 10.1002/Cncr.31063  0.32
2015 Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Mitchell FT, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar A, et al. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prevention Research (Philadelphia, Pa.). PMID 26342026 DOI: 10.1158/1940-6207.Capr-14-0179  0.32
2015 Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, James N, Rettig EM, Guo T, Pickering CR, Bishop JA, Chung CH, Califano JA, Eisele DW, Fakhry C, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Science Translational Medicine. 7: 293ra104. PMID 26109104 DOI: 10.1126/Scitranslmed.Aaa8507  0.32
2015 Woo SH, Yang LP, Chuang HC, Fitzgerald A, Lee HY, Pickering C, Myers JN, Skinner HD. Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence. Head & Neck. PMID 25994759 DOI: 10.1002/Hed.24129  0.32
2015 Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, et al. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Research. 75: 1205-15. PMID 25691460 DOI: 10.1158/0008-5472.Can-14-2729  0.32
2015 Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, et al. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Research. 75: 1527-36. PMID 25634208 DOI: 10.1158/0008-5472.Can-14-2735  0.32
2015 Pickering CR, Bast RC, Keyomarsi K. How will we recruit, train, and retain physicians and scientists to conduct translational cancer research? Cancer. 121: 806-16. PMID 25355050 DOI: 10.1002/cncr.29033  0.32
2015 Nagarajan M, Wilkins AD, Bachman BJ, Novikov IB, Bao S, Haas PJ, Terrón-Díaz ME, Bhatia S, Adikesavan AK, Labrie JJ, Regenbogen S, Buchovecky CM, Pickering CR, Kato L, Lisewski AM, et al. Predicting future scientific discoveries based on a networked analysis of the past literature Proceedings of the Acm Sigkdd International Conference On Knowledge Discovery and Data Mining. 2015: 2019-2028. DOI: 10.1145/2783258.2788609  0.32
2014 Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6582-92. PMID 25303977 DOI: 10.1158/1078-0432.Ccr-14-1768  0.32
2014 Pickering CR, Zhang J, Neskey DM, Zhao M, Jasser SA, Wang J, Ward A, Tsai CJ, Ortega Alves MV, Zhou JH, Drummond J, El-Naggar AK, Gibbs R, Weinstein JN, Wheeler DA, et al. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3842-8. PMID 24874835 DOI: 10.1158/1078-0432.Ccr-14-0565  0.32
2014 Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, Yegnasubramanian S, Hadar T, Noordhuis MG, Zizkova V, Fertig E, Agrawal N, Westra W, Koch W, Califano J, et al. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1031-46. PMID 24786473 DOI: 10.4161/Epi.29025  0.32
2014 Bailey AM, Zhan L, Maru D, Shureiqi I, Pickering CR, Kiriakova G, Izzo J, He N, Wei C, Baladandayuthapani V, Liang H, Kopetz S, Powis G, Guo GL. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. American Journal of Physiology. Gastrointestinal and Liver Physiology. 306: G48-58. PMID 24177031 DOI: 10.1152/Ajpgi.00234.2013  0.32
2014 Hah JH, Zhao M, Pickering CR, Frederick MJ, Andrews GA, Jasser SA, Fooshee DR, Milas ZL, Galer C, Sano D, William WN, Kim E, Heymach J, Byers LA, Papadimitrakopoulou V, et al. HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells. Head & Neck. 36: 1547-54. PMID 24123531 DOI: 10.1002/Hed.23499  0.32
2014 Spangler S, Wilkins AD, Bachman BJ, Nagarajan M, Dayaram T, Haas P, Regenbogen S, Pickering CR, Comer A, Myers JN, Stanoi I, Kato L, Lelescu A, Labrie JJ, Parikh N, et al. Automated hypothesis generation based on mining scientific literature Proceedings of the Acm Sigkdd International Conference On Knowledge Discovery and Data Mining. 1877-1886. DOI: 10.1145/2623330.2623667  0.32
2013 Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 4: 1388-98. PMID 23963114 DOI: 10.18632/Oncotarget.1239  0.32
2013 Gadhikar MA, Sciuto MR, Alves MV, Pickering CR, Osman AA, Neskey DM, Zhao M, Fitzgerald AL, Myers JN, Frederick MJ. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Molecular Cancer Therapeutics. 12: 1860-73. PMID 23839309 DOI: 10.1158/1535-7163.Mct-13-0157  0.32
2013 Pickering CR, Shah K, Ahmed S, Rao A, Frederick MJ, Zhang J, Unruh AK, Wang J, Ginsberg LE, Kumar AJ, Myers JN, Hamilton JD. CT imaging correlates of genomic expression for oral cavity squamous cell carcinoma. Ajnr. American Journal of Neuroradiology. 34: 1818-22. PMID 23764725 DOI: 10.3174/Ajnr.A3635  0.32
2013 Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer. 119: 3034-42. PMID 23696076 DOI: 10.1002/Cncr.28150  0.32
2013 Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discovery. 3: 770-81. PMID 23619168 DOI: 10.1158/2159-8290.Cd-12-0537  0.32
2013 Pickering CR, Myers JN. Bcl-2 inhibition or FBXW7 mutation sensitizes solid tumor cells to HDAC inhibition in vitro but could prove difficult to validate in patients. Cancer Discovery. 3: 258-9. PMID 23475877 DOI: 10.1158/2159-8290.Cd-13-0019  0.32
2013 Loyo M, Li RJ, Bettegowda C, Pickering CR, Frederick MJ, Myers JN, Agrawal N. Lessons learned from next-generation sequencing in head and neck cancer. Head & Neck. 35: 454-63. PMID 22907887 DOI: 10.1002/Hed.23100  0.32
2012 Sandulache VC, Skinner HD, Ow TJ, Zhang A, Xia X, Luchak JM, Wong LJ, Pickering CR, Zhou G, Myers JN. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status. Cancer. 118: 711-21. PMID 21720999 DOI: 10.1002/Cncr.26321  0.32
2011 Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, Myers JN. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6658-70. PMID 21903770 DOI: 10.1158/1078-0432.Ccr-11-0046  0.32
2011 Zhao M, Sano D, Pickering CR, Jasser SA, Henderson YC, Clayman GL, Sturgis EM, Ow TJ, Lotan R, Carey TE, Sacks PG, Grandis JR, Sidransky D, Heldin NE, Myers JN. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7248-64. PMID 21868764 DOI: 10.1158/1078-0432.Ccr-11-0690  0.32
2011 Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (New York, N.Y.). 333: 1154-7. PMID 21798897 DOI: 10.1126/Science.1206923  0.32
2011 Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JN. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 117: 2926-38. PMID 21692052 DOI: 10.1002/Cncr.25868  0.32
2010 Fordyce C, Fessenden T, Pickering C, Jung J, Singla V, Berman H, Tlsty T. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. Cancer Prevention Research (Philadelphia, Pa.). 3: 190-201. PMID 20028875 DOI: 10.1158/1940-6207.Capr-09-0229  0.32
2006 Zhang J, Pickering CR, Holst CR, Gauthier ML, Tlsty TD. p16INK4a modulates p53 in primary human mammary epithelial cells. Cancer Research. 66: 10325-31. PMID 17079452 DOI: 10.1158/0008-5472.Can-06-1594  0.32
2005 Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Research. 65: 1792-9. PMID 15753376 DOI: 10.1158/0008-5472.Can-04-3507  0.32
2001 Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE, Donehower LA. Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing Toxicologic Pathology. 29: 147-154. PMID 11695551 DOI: 10.1080/019262301753178555  0.32
Show low-probability matches.